一、企业背景与转型动因江西银涛药业股份有限公司是一家集研发、生产、销售为一体的国家高新技术企业,业务涵盖中成药、化学原料药、制剂等领域,产品涉及9大类别、18大系列、158个药品批文。企业下辖多家子公司,具备完整的产业链布局与创新研发体系。在新医改、集采政策、市场竞争加剧、监管收紧等因素影响下,银涛药业面临诸多挑战:- 缺乏统一信息化平台,母子公司之间存在数据孤岛,难以满足IPO标准化上市流程;-...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.